CICompany report
Cincinnati Financial Corporation CINF
The bet you're really making is that Cincinnati Financial keeps collecting more in home and business insurance premiums than it pays out in claims, selling through local independent agents across the country. You're also betting on a habit almost no other insurer shares: it keeps over $13 billion parked in the stock market, so the company looks brilliant when stocks rise and broken when they fall. Right now, one thing to watch: reported profit jumped 83% on the stock market, while the actual insurance profit fell 28% as claims outran premiums. You pay about 1.6 times what the company is worth on paper, toward the high end of its range over the last twelve years, and about 20 times a normal year's earnings.
Key data
CINF · price with moving averages
Source: market data.
The business
Cincinnati Financial sells property and casualty insurance, commercial policies for small and mid-sized businesses plus homeowners and auto, through a network of independent local agents who also carry rival carriers. Its edge is those agent relationships, decades deep, and a willingness to write coverage on prices set from its own loss data. What separates it from every peer is the balance sheet. Instead of parking reserves entirely in bonds, Cincinnati holds $13.2 billion of common stocks, worth three times their $4.3 billion cost. That portfolio, not underwriting, is why reported profit lurches from a $487 million loss in 2022 to $2.4 billion in 2025. The insurance is the business, the stock portfolio is the leverage, and it cuts both ways.
The numbers
Read the quarters on operating income, because the headline is a stock ticker in disguise.
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q2 2025 | $3.2B | $685M | $4.34 |
| Q3 2025 | $3.7B | $1.12B | $7.11 |
| Q4 2025 | $3.1B | $676M | $4.29 |
| Q1 2026 | $2.9B | $274M | $1.75 |
| Q2 2026 | $4.3B | $1.26B | $8.05 |
Diluted EPS swings from $1.75 to $8.05 in two quarters, and almost none of that is insurance. The 10-Q is blunt: $3.26 of the $3.71 second-quarter EPS gain over last year came from the changing value of stocks the company still holds and has not sold. Strip the marks and the picture inverts. Operating income, the profit from underwriting plus investment income, fell to $224 million from $311 million a year earlier, and the operating result came in at $1.43 against a $1.84 consensus estimate, about 22% short. Insurance losses rose roughly 14% while premiums grew slower, so the underwriting margin thinned.
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2021 | $9.6B | $3.0B | $18.24 |
| 2022 | $6.6B | -$487M | -$3.06 |
| 2023 | $10.0B | $1.8B | $11.66 |
| 2024 | $11.3B | $2.3B | $14.53 |
| 2025 | $12.6B | $2.4B | $15.17 |
| 2026, 1H to June | $7.1B | $1.5B | $9.78 |
Across the fiscal years the same tell repeats: 2022's loss was the equity portfolio, not a blown underwriting year. Book value is the real scoreboard, and management measures itself by the Value Creation Ratio, book-value growth plus dividends, targeting 10% to 13% a year and averaging 13.8% over 2021 through 2025. Book value per share climbed to about $109 from roughly $92 a year ago, an 18% increase, though a large slice of that is unrealized equity gains that can reverse in a quarter. Return on equity screens at 21%, but the stock market is flattering the numerator, and on operating earnings the return sits closer to the low teens, respectable for a carrier and no better.
| Q2 | Net investment income | Operating income | GAAP net income |
|---|---|---|---|
| 2025 | $285M | $311M | $685M |
| 2026 | $319M | $224M | $1.3B |
The lens table holds the whole argument in two rows: the steady engine, investment income, is up 12% as maturing bonds roll into higher yields, while the thing you actually underwrite for, operating profit, fell 28%, and only the stock market made the reported number look like a triumph. What this memo believes that the tape does not: the market is paying a top-of-range multiple for a company whose underlying insurance profit is currently shrinking, and the next operating-EPS print, not the GAAP figure, settles whether Q2 was a weather quarter or a trend.
Management
The record is mixed and worth reading closely. Two insiders moved this summer, director Dirk Debbink bought $172,000 of stock on August 25, and a member of the Schiff family, descendants of the founders, sold $1.33 million on August 3, plan status not disclosed. Capital return accelerated hard: the company repurchased $394 million of stock in the first half, nearly double the $205 million bought in all of 2025, and the board authorized another 15 million shares in August. Those buybacks happen at about 1.6 times book value, so management is paying up for its own shares, defensible only if book keeps compounding at the low-teens VCR. The dividend, raised every year for over six decades, is the one promise this company has never broken.
How it fails or surprises you
Claims outrun premiums for a second quarter. Operating income already fell 28% year over year and the operating number came 22% under estimate. If Q3 repeats it, losses up double digits and premiums lagging, then Q2 was a trend, not weather, and a 20-times operating multiple loses its footing. The first tell is Q3 operating EPS against the roughly $2 consensus now carries.
The stock market falls and takes book value with it (left tail). Over $13 billion in equities, $8.9 billion of it unrealized gains, sits inside book value. A 20% market drop erases about $2.6 billion, roughly 16% of the $16.7 billion equity base, in a single quarter, exactly what turned 2022 into a reported loss. No underwriting skill offsets it, and you cannot diversify it away by owning the shares.
Higher yields compound the quiet engine (right tail). Net investment income rose 12% and interest income 14% as old low-coupon bonds mature into today's rates, a tailwind that runs for years and that nobody prices because it is dull. If underwriting merely holds while investment income compounds high-single-digits, operating earnings re-rate the multiple upward without a single dramatic quarter.
Closing thoughts
The next operating result will show whether this is a real problem or a quarterly fluke. The GAAP number is noise, the signal is next quarter's operating EPS. A second miss converts today's top-of-range multiple into an obvious mistake and the stock drifts toward its historical 1.4 times book. A clean operating quarter says Q2 was catastrophe timing and the compounding case holds. The left tail, a market drop dragging book down, is fatter than the portfolio's steady lift suggests, because the same $13 billion that has powered book value for a decade is the thing that breaks it in a bad year. What is at risk if underwriting keeps sliding is the whole premium over book, and what the right tail is worth is years of quiet investment-income compounding the market hands you for free.
The bet is still that Cincinnati keeps collecting more in premiums than it pays in claims, and that its unusual pile of stocks compounds faster than it occasionally crashes. What breaks it is the pair that just moved the wrong way, operating income down 28% while claims grew about 14%. Watch those two lines next quarter. If operating income turns back up while premiums outgrow claims, the price is fair, and if claims keep winning, you are paying a record multiple for a shrinking insurance business wrapped around a stock portfolio you could own yourself.
Methodology
Valuation basis: a P&C insurer is judged on price to book and normalized operating earnings, not GAAP net income, because equity-portfolio marks flow straight through the income statement.
Data gaps: Q4 2025 quarterly figures are derived from full-year less nine months and foot to the annual filing; the clean P&C combined ratio is not separately isolable from the pulled 10-Q, so underwriting direction is read from losses, expenses and operating income; price-to-book is computed from filed Q2 2026 equity and current market cap (1.6x), against a vendor peer figure of about 2.1x.
Bundle: Cincinnati Financial filings covering fiscal 2021 through 2025 and the five most recent reported quarters through Q2 2026, period ended June 30, 2026.
Sources: filed 10-Q (2026-07-27) income statement and balance sheet, the August 8-K investor handout and repurchase authorization, insider Form 4 records, and vendor market and consensus data as of September 6, 2026.
Fact check: Corrected book value increase from 17% to 18% (based on filed equity and share count calculation). Q4 2025 quarterly figures derived from annual minus first three quarters. Unrealized equity gains ($8.9B) and 20% drop impact ($2.6B) calculated from filed balance sheet values. All critical figures, operating income ($224M vs $311M), EPS miss ($1.43 vs $1.84 estimate), investment income growth (+12%), insurance losses increase (≈14%), buyback amounts ($394M 1H26 vs $205M FY25), insider transactions, VCR targets (10-13%, averaged 13.8%), and the $3.26 EPS attribution to equity marks, reconciled to the 10-Q filed 2026-07-27 and August 2026 8-K filings. Final analysis verified as of Sep 6, 2026.
Bid Cap
Daily ideas, a 390-name database, and a model long/short book from an investor who mostly covers financials. $70 a month or $700 a year.
Subscribe on Substack


